NCT01434888 - Pharmacokinetics, Safety and Tolerability of the Preservative-free Fixed Dose Combination of Tafluprost 0.0015% and Timolol 0.5% Eye Drops | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

September 30, 2011

Primary Completion Date

December 31, 2011

Study Completion Date

December 31, 2011

Conditions

Healthy Volunteers

Interventions

DRUG

Preservative free tafluprost 0.0015% eye drops

Preservative free tafluprost eye drops will be administered once daily at 09:00 into both eyes for seven days. For masking purposes vehicle eye drops will be administered in the evening at 21:00.

DRUG

Preservative free timolol 0.5% eye drops

Preservative free timolol eye drops will be administered into both eyes twice daily at 9:00 and 21:00 for seven days

DRUG

Preservative free FDC of tafluprost 0.0015% and timolol 0.5% eye drops

Preservative free fixed-dose combination eye drops will be administered into both eyes once daily at 9:00 for seven days. For masking purposes vehicle eye drops will be administered in the evening at 21:00.

Trial Locations (1)

70200

Kuopio University Hospital Eye Clinic, Kuopio

All Listed Sponsors

lead

Santen Oy

INDUSTRY